Exact Mass: 540.1378

Exact Mass Matches: 540.1378

Found 21 metabolites which its exact mass value is equals to given mass value 540.1378, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Pilaralisib

2-amino-N-[3-({3-[(2-chloro-5-methoxyphenyl)amino]quinoxalin-2-yl}sulfamoyl)phenyl]-2-methylpropanamide

C25H25ClN6O4S (540.1346)

C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C2152 - Phosphatidylinositide 3-Kinase Inhibitor C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor

Floribundiquinone C

C31H24O9 (540.142)

Afzelone A

C31H24O9 (540.142)

6-O-[(6-O-allophanyl)-beta-D-glucopyranosyl]-5-hydroxy-7-phenyl-3H-benzo[de]isochromen-1-one

C26H24N2O11 (540.138)

(1R,2S)-1-(6-bromo-2-methoxyquinolin-3-yl)-4-(methylamino)-2-naphthalen-1-yl-1-phenylbutan-2-ol

C31H29BrN2O2 (540.1412)

Garenoxacin Mesylate

C24H26F2N2O8S (540.1378)

C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic

Oxytetracycline, disodium salt, dihydrate

C22H26N2Na2O11 (540.1332)

D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents

Sceptrin dihydrochloride

C22H25BrN10O2 (540.1345)

Acriflavine (hydrochloride)

C27H27Cl3N6 (540.1363)

Acriflavine hydrochloride (Acriflavinium chloride hydrochloride) is a fluorescent acridine dye that can be used to label nucleic acid[1][2]. Acriflavine hydrochloride is an antiseptic. Acriflavine hydrochloride is a potent HIF-1 inhibitor, with antitumor activity. Acriflavine hydrochloride has antimicrobial and antiviral activities[3][4][5]. Acriflavine hydrochloride is a potent papain-like protease (PLpro) inhibitor, which inhibits SARS-CoV-2[6]

10-(6-acetyl-7-hydroxy-5-methyl-1,4-dioxonaphthalen-2-yl)-3,8-dihydroxy-1,7,10-trimethyl-9-oxoanthracene-2-carboxylic acid

C31H24O9 (540.142)

(5s,6s,12s)-6-(2,4-dihydroxybenzoyl)-8-hydroxy-12-(4-hydroxyphenyl)-5-(4-methoxyphenyl)-4,13-dioxatricyclo[7.4.0.0³,⁷]trideca-1(9),2,7-trien-10-one

C31H24O9 (540.142)

7-hydroxy-10-phenyl-8-[(3,4,5-trihydroxy-6-{[hydroxy(c-hydroxycarbonimidoylimino)methoxy]methyl}oxan-2-yl)oxy]-3-oxatricyclo[7.3.1.0⁵,¹³]trideca-1(13),5,7,9,11-pentaen-2-one

C26H24N2O11 (540.138)

7-hydroxy-10-phenyl-8-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-{[hydroxy(c-hydroxycarbonimidoylimino)methoxy]methyl}oxan-2-yl]oxy}-3-oxatricyclo[7.3.1.0⁵,¹³]trideca-1(13),5,7,9,11-pentaen-2-one

C26H24N2O11 (540.138)

(1r,3s)-5-(1,8-dihydroxy-6-methyl-9,10-dioxoanthracen-2-yl)-10-hydroxy-7-methoxy-1,3-dimethyl-1h,3h,4h-naphtho[2,3-c]pyran-6,9-dione

C31H24O9 (540.142)

n-{[2,3-bis(2-imino-1,3-dihydroimidazol-4-yl)-4-[(1h-pyrrol-2-ylformamido)methyl]cyclobutyl]methyl}-4-bromo-1h-pyrrole-2-carboxamide

C22H25BrN10O2 (540.1345)

(5s,6s)-6-(2,4-dihydroxybenzoyl)-8-hydroxy-12-(4-hydroxyphenyl)-5-(4-methoxyphenyl)-4,13-dioxatricyclo[7.4.0.0³,⁷]trideca-1(9),2,7-trien-10-one

C31H24O9 (540.142)

n-{[(1r,2s,3s,4r)-2,3-bis(2-imino-1,3-dihydroimidazol-4-yl)-4-[(1h-pyrrol-2-ylformamido)methyl]cyclobutyl]methyl}-4-bromo-1h-pyrrole-2-carboxamide

C22H25BrN10O2 (540.1345)

5-(1,8-dihydroxy-6-methyl-9,10-dioxoanthracen-2-yl)-10-hydroxy-7-methoxy-1,3-dimethyl-1h,3h,4h-naphtho[2,3-c]pyran-6,9-dione

C31H24O9 (540.142)